Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Ellingson, B. M., Gerstner, E. R., Lassman, A. B., Chung, C., Colman, H., Cole, P. E., Leung, D., Allen, J. E., Ahluwalia, M. S., Boxerman, J., Brown, M., Goldin, J., Nduom, E., Hassan, I., Gilbert, M. R., Mellinghoff, I. K., Weller, M., Chang, S., Arons, D., … Cloughesy, T. F. (2022). Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. Neuro-Oncology, 24(8), 1219–1229. https://doi.org/10.1093/neuonc/noac086
Authors:
Benjamin M Ellingson
Elizabeth R Gerstner
Andrew B Lassman
Caroline Chung
Howard Colman
Patricia E Cole
David Leung
Joshua E Allen
Manmeet S Ahluwalia
Jerrold Boxerman
Matthew Brown
Jonathan Goldin
Edjah Nduom
Islam Hassan
Mark R Gilbert
Ingo K Mellinghoff
Michael Weller
Susan Chang
David Arons
Clair Meehan
Wendy Selig
Kirk Tanner
W. K Alfred Yung
Martin Van Den Bent
Patrick Y Wen
Timothy F Cloughesy
Affiliated Authors:
Joshua E Allen
Subjects:
Author Keywords:
response assessment
brain tumors
clinical trials
growth rates
Publication Type:
Article
Unique ID:
10.1093/neuonc/noac086
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: